Article

Perioperative GLY-GLN infusion diminishes the surgery-induced period of immunosuppression: accelerated restoration of the lipopolysaccharide-stimulated tumor necrosis factor-alpha response.

Surgical Research Laboratories, University of Vienna, Austria.
Annals of Surgery (Impact Factor: 7.19). 02/2003; 237(1):110-5. DOI: 10.1097/01.SLA.0000041040.98684.CB
Source: PubMed

ABSTRACT To investigate whether the administration of different glutamine-containing dipeptides, glycyl-l-glutamine (GLY-GLN) and l-alanyl-l-glutamine, has a differing impact on perioperative immunomodulation.
Surgery leads to transitory immunosuppression, which is associated with decreased plasma glutamine (GLN) levels and increased susceptibility to infection and sepsis. A useful tool to detect immunocompetence is the ex vivo lipopolysaccharide (LPS)-stimulated tumor necrosis factor alpha (TNF-alpha) secretion in whole blood.
Forty-five patients undergoing major abdominal surgery were randomized prospectively to receive 0.5 g/kg/24 h GLN dipeptides administered as GLY-GLN or as ALA-GLN or isonitrogenous Vamin (a GLN-free amino acid solution; control group) as a continuous infusion over 72 hours, starting 24 hours before surgery. Blood samples were collected before infusion, at the end of surgery, and 48 hours postoperatively to determine the TNF-alpha release into whole blood stimulated with LPS. Groups were compared by analysis of variance.
The groups were comparable in age, gender distribution, and length of operative time. At the end of surgery a significant reduction in ex vivo LPS-stimulated TNF-alpha production was observed in all groups. In patients who received GLY-GLN, the induced TNF-alpha production was restored after 48 hours.
In this study perioperative infusion of GLY-GLN reduced immunosuppression. The effect of GLN-containing dipeptides seems to be different when administered in glycine or alanine form.

0 Bookmarks
 · 
71 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: The study reported here aimed to analyze the anti-inflammatory and immunmodulatory impact of arginine, glycine, glutamine, and the combination of these amino acids on the intracellular expression of proinflammatory cytokines during sepsis. These amino acids were tested on lipopolysaccharide (LPS)-stimulated human monocytes in a whole-blood system and examined using flow cytometry. Materials and methods: The whole blood of twelve healthy volunteers processed immediately after withdrawal was incubated with arginine (2 and 5 mM), glycine (2 and 5 mM), glycyl-glutamine (2 and 5 mM), and the amino acid and dipeptide solution Glamin® (Fresenius Kabi, Bad Homburg, Germany) at three concentrations (5%, 10%, 20%), with or without LPS (0.2 ng/mL) stimulation. Cytokine-producing monocytes were phenotyped in whole blood and the intracellular expression of interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α was assessed by flow cytometry. Results: In whole-blood samples from volunteers, used to best imitate physiological cellular interactions, the amino acid and dipeptide solution Glamin, containing arginine, glycine, glycyl-glutamine, was able to significantly and dose-dependently diminish LPS-induced production of proinflammatory cytokines such as IL-6, IL-8, and TNF-α in human monocytes. However, single incubation with the amino acids arginine, glycine, and glycyl-glutamine individually did not affect alterations in the expression of IL-6, IL-8, or TNF-α. Conclusion: The amino acid and dipeptide solution Glamin, composed of glycine, arginine, and glycyl-glutamine, had strong anti-inflammatory and immunomodulatory effects during the induced experimental sepsis, as it significantly downregulated intracellular expression of proinflammatory cytokines in human whole-blood monocytes. However, only incubation with a combination of amino acids (ie, Glamin), rather than individual amino acids, demonstrated an inhibitory impact on cytokine production in LPS-stimulated monocytes. The results indicate that a combination of amino acids may potentiate the anti-inflammatory response, leading to a marked suppression of TNF-α, IL-6, and IL-8 during sepsis. Keywords: sepsis, anti-inflammatory response, glycine, arginine, glycyl-glutamine, Glamin®
    International Journal of Interferon, Cytokine and Mediator Research 05/2013; 2013(5):1-10.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background & aims: To determine whether perioperative glutamine supplementation of parenteral nutrition (PN) has an impact on morbidity and mortality of patients with previous moderate to severe risk of malnutrition. Methods: A quasi-experimental study was conducted comparing the following groups: Control group 1: without glutamine dipeptide supplementation of PN during the perioperative period. Control group 2: PN was supplemented with glutamine dipeptide (0.4 g/kg/day) after surgery only. Group 3 (follow-up group): PN was supplemented with glutamine dipeptide (0.4 g/kg/day) in the perioperative period. Postoperative morbidity and mortality was recorded. Results: Sixty-seven patients matched for baseline and surgical characteristics were recruited into the study. Univariate analysis showed a lower incidence of hyperglycemia and ICU admission in group 3, and a trend to significance (P = 0.078) in terms of a lower incidence of infection. In the multivariate analysis, only group 3 met the models of ICU admission (OR = 0.28), hyperglycemia (OR = 0.11), and renal failure (OR = 0.19). Conclusions: The results show that perioperative use of glutamine dipeptide in patients at risk of moderate to severe malnutrition before surgery is an effective option for decreasing the morbidity associated with malnutrition, as it improves blood glucose modulation and reduces infection and ICU stay.
    Nutricion hospitalaria: organo oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral 12/2011; 26(6):1305-1312. · 1.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Surgery and immunotherapy are mainstays of the treatment of renal cell carcinoma. Disease confined to the kidney can be cured by surgery alone. However, up to 19% of patients with histopathologically organ-confined disease (i.e., tumor stage pT1-2N0M0 or ROBSON I) die from tumor recurrence in the first 5 years after tumor nephrectomy (Lam et al. 2007). Some reasons and histopathological considerations were reviewed by the authors (Böhm et al., 2002, 2003). Even if one considers the methodological hazards of using different systems of tumor classi­fication (ROBSON versus UICC-TNM classification, modifications of the TNM clas­-sification in 1987, 1997, and 2002) it appears that more patients die from recurrent disease after surgically complete resection than can be expected from the frequency of undetected micrometastases at the time of operation. For this and other reasons the suggestion by (Robson et al. 1969) that the renal artery be ligated first and then the specimen be resected and removed en bloc is still valued in many surgical departments. Surgery, including renal surgery is associated with complex perioperative immunodysfunction (Böhm et al. 2001). This involves both cellular and humoral components of the immune system. It was noted that less surgical trauma is associated with less perioperative immunodysfunction and hence better outcome (Whitson et al. 2007), but this association has been challenged (Landman et al. 2004).

Full-text (2 Sources)

Download
14 Downloads
Available from
May 21, 2014